Publication | Closed Access

Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis

Rheumatoid DisorderRheumatologyAutoimmune DiseaseLupusMedicineImmunologyTarget-mediated Drug DistributionBiological TherapyInflammatory Rheumatic DiseasePharmacokinetics AnalysisImmunotherapyPharmacologyNovel TherapyRheumatoid ArthritisDrug Discovery